JeanMarie Guenot, Exceptional President and CEO of a Biotechnology Conglomerate

Amphivena Therapeutics, Inc., founded in 2013 and based in San Francisco, is an innovative company that is happy to be led by its President and CEO, Dr. JeanMarie Guenot, due to her extensive experience, her passion for her life’s work, and her determination to help the developer of immune therapies for the treatment of cancer in its quest to eradicate blood cancers and restore cellular balance.


It is Amphivena’s belief that when blood forms, functions, and circulates properly, the body’s immune system will destroy tumors and their precursors. Their committed goal is to give patients suffering from hematologic malignancies such as leukemia the best available treatment options.


Dr. JeanMarie Guenot acquired her Ph.D at the University of California, San Francisco, one of the world’s leading universities in health sciences, and her MBA from the prestigious Wharton School at the University of Pennsylvania. She has 20 years of experience in the pharmaceutical and biotechnology industries and in building and rebuilding companies.


As her Facebook page indicates, Jeanmarie’s scientific career began as the preclinical R&D principal scientist at Hoffmann-La Roche, where she helped to develop drugs for oncology, autoimmune diseases, metabolic diseases, and inflammation. In addition, through her own company, Guenot LLC, she provides specialized consultation services for pharmaceuticals and biotechnology companies relative to commercial planning, project and finance management, venture capital, mergers, and acquisitions.


Before Amphivena, Dr. Guenot served in various companies in different roles included being the business consultant for Hoffmann in Shangai and Basel for one year and the vice-president of Corporate and Business Development at PDL BioPharma, which led to a successful deal between PDL and Hoffmann-La Roche and PDL.


As an acknowledgment of her efforts, she received the Deal of Distinction Award in 2006 from the Licensing Executive Society and the Innovative Bio-Partnering Award from BioBusiness Network in 2005.  Read more about her accomplishments on Jeanmarie Guenot’s LinkedIn page:

Leave a Reply